GUSBP1
Putative inactive beta-glucuronidase-like protein SMA3
Also known as: GUSP1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for GUSBP1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
140 residues, UniProt reviewed canonical sequence.
>Q15486|GUSBP1
1 MDRSNPVKPA LDYFSNRLVN YQISVKCSNQ FKLEVCLLNA ENKVVDNQAG TQGQLKVLGA
61 NLWWPYLMHE HPASLYSWED GDCSHQSLGP LPACDLCDQL HLRSRQGGSV CGCDPCEQLL
121 LLVSQLRAPG VDSAAAGRPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GUSBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GUSBP1 as an antibody target. Whether an autoantibody or antibody against GUSBP1 could matter depends on whether native GUSBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GUSBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GUSBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...